Lexicon Pharmaceuticals (LXRX)
NASDAQ:LXRX
Holding LXRX?
Track your performance easily

Lexicon Pharmaceuticals (LXRX) Financial Statements

1,387 Followers

Lexicon Pharmaceuticals Financial Overview

Lexicon Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.772; its P/E ratio is -1.54; Lexicon Pharmaceuticals is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $-0.16. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 1.65M$ 317.00K--$ 39.00K
Gross Profit$ 1.48M$ 30.29M---
EBIT$ -53.43M$ 17.07M$ -7.26M-$ -22.52M
EBITDA$ -52.77M$ 17.49M$ -6.89M-$ -22.41M
Net Income Common Stockholders$ -53.43M$ -44.90M$ -9.09M-$ -23.39M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 309.96M$ 256.74M$ 105.94M$ 138.36M$ 136.20M
Total Assets$ 373.36M$ 316.90M$ 162.72M$ 194.30M$ 191.69M
Total Debt$ 99.50M$ 98.77M$ 48.84M$ 0.00$ 30.63M
Net Debt$ -210.46M$ -157.97M$ -57.09M$ -138.36M$ -105.58M
Total Liabilities$ 133.38M$ 130.36M$ 74.67M$ 450.72M$ 47.67M
Stockholders Equity$ 239.98M$ 186.36M$ 88.05M$ 422.12M$ 144.02M
Cash Flow-
Free Cash Flow$ -48.79M$ -38.26M$ -31.86M-$ -19.44M
Operating Cash Flow$ -48.54M$ -38.12M$ -31.61M-$ -19.44M
Investing Cash Flow$ -12.32M$ -74.61M$ 12.09M-$ -77.20M
Financing Cash Flow$ -14.00K$ 188.96M$ -824.00K-$ 94.02M
Currency in USD

Lexicon Pharmaceuticals Earnings and Revenue History

Lexicon Pharmaceuticals Debt to Assets

Lexicon Pharmaceuticals Cash Flow

Lexicon Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis